Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioasis Technologies Inc (BIOAF)

Bioasis Technologies Inc (BIOAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bioasis Technologies Inc 157 Church Street 19th floor New Haven CT 06510 USA

www.bioasis.us P: 203-533-7082

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

biOasis Technologies Inc. is a biopharmaceutical company. It is focused on developing and commercializing proprietary pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The Company is engaged in the development of a vector (Transcend) for the transport of therapeutic agents across the blood brain barrier and the development of an in vitro diagnostic assay to assist physicians in diagnosis of Alzheimer's disease (Cognitest). biOasis Technologies Inc. is headquartered in Vancouver, Canada.

Key Statistics

Overview:

Market Capitalization, $K 16
Enterprise Value, $K -164
Shares Outstanding, K 79,410
Annual Sales, $ 30 K
Annual Net Income, $ -2,360 K
Last Quarter Sales, $ 110 K
Last Quarter Net Income, $ -730 K
EBIT, $ -1,220 K
EBITDA, $ -1,180 K
60-Month Beta 0.55
% of Institutional Shareholders 0.00%
Float, K 72,910
% Float 100.00%
Short Volume Ratio 1.00

Growth:

1-Year Return 100.00%
3-Year Return -99.91%
5-Year Return -99.91%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 01/01/70
Earnings Per Share ttm -0.02
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BIOAF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -7,866.67%
Debt/Equity -0.56
Price/Sales 0.08
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.03
Interest Coverage -3.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar